[stephanheijl]

Designing novel viral proteins might become trivial, but actually doing the lab work to produce them would still be a tough exercise. On the other hand, exactly by the mechanism that would give rise to such a novel pathogen, actors that do have access to large manufacturing capabilities would be able to create novel drugs rapidly or even prevantatively.

[KidComputer]

It’s difficult, but doable and nowhere near as hard as the synthetic chemistry need to produce small molecule therapeutics to fight novel pathogens. The hardest part in my opinion would be getting accurate predictions of protein-protein binding free energies.

> create novel drugs rapidly or even prevantatively. On your final point I’m skeptical. Drugs are difficult to design because you need to account for off-target effects among other things. That’s not a concern when designing a harmful agent. Furthermore I presume one could intelligently harden the pathogen so any potential treatment might be as harmful as the pathogen itself. But that’s a strong assumption and I know of no way to formally verify it.